BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 943328)

  • 1. [Study of the acute and chronic toxicity of a new preparation of the 3,5-dioxopyrazolidine series, butaglionamide, in comparison with amidopyrine and butadione].
    Voronkova LA; Bertash VI
    Farmakol Toksikol; 1976; 39(1):98-101. PubMed ID: 943328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazoline-5-one and pyrazolidine-3, 5-dione derivatives with antiphlogistic and analgesic activity.
    Nardi D; Massarani E; Magistretti MJ
    Arzneimittelforschung; 1969 Oct; 19(10):1721-3. PubMed ID: 5395471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxicity of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP)].
    Tanabe K; Takaori S; Shimamoto K
    Nihon Yakurigaku Zasshi; 1967 May; 63(3):105-22. PubMed ID: 6069762
    [No Abstract]   [Full Text] [Related]  

  • 4. Some toxicological aspects of a nicotinamide-methylaminopyrazolone (Ra 101).
    Tubaro E; Bulgini MJ; Del Grande P; Monai A
    Arzneimittelforschung; 1970 Aug; 20(8):1024-9. PubMed ID: 4394829
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamics of anti-inflammatory preparations in body exposure to a physical therapeutic factor].
    Leshchinskiĭ AF; Zolotareva TA; Karpenchuk OT; Zuza ZI
    Farmakol Toksikol; 1979; 42(3):265-9. PubMed ID: 446707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the pharmacodynamics of morphine and aminopyrine under conditions of alloxan diabetes].
    El'tsova ZI; Komendantova MV
    Farmakol Toksikol; 1976; 39(1):14-8. PubMed ID: 943314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and screening of some substituted 3.5-dioxopyrazolidines.
    Nasr H; El-Zanfally S; Khalifa M; Abu-Shady H
    Pharmazie; 1976 Nov; 31(11):774-5. PubMed ID: 1023241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible toxic effects on hemopoietic system of combination of equal parts of phenylbutazone and aminopyrine].
    COBRA CJ; D'AURIA H; MENDES FT
    Rev Bras Med; 1958 May; 15(5):322-5. PubMed ID: 13591665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of heptachlorine on amidopyrine toxicity].
    Vargová M; Kovalcík V
    Bratisl Lek Listy; 1975 Jan; 63(1):87-92. PubMed ID: 1116031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyrazolone and dioxopyrazolidine].
    KROHS W; HENSEL O
    Arzneimittelforschung; 1961; Suppl 11():1-488. PubMed ID: 14035918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of N-demethylation of amidopyrine with the supernatant portion of the centrifugate of new-born and adult rat liver in the presence of barbital, phenobarbital and phenylbutazone].
    Klinger V
    Farmakol Toksikol; 1972; 35(1):63-8. PubMed ID: 5011520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxicodermia after wofapyrin].
    WOLFRAM G
    Dtsch Gesundheitsw; 1960 Apr; 15():722-9. PubMed ID: 13845735
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of some pyrazolone derivatives on thrombocyte aggregation].
    Lakin KM; Krylov IuF; Maliugin AF; Nepsha VD; Moldaver BL
    Farmakol Toksikol; 1976; 39(2):180-6. PubMed ID: 1278350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological properties of the methylamide of N-(4-antipyril)-oxaminic acid (oxapyrine)].
    Sangaĭlo AK; Pastukhova TP
    Farmakol Toksikol; 1976; 39(2):148-51. PubMed ID: 1278345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mathematical optimization of the technology for preparing tablets containing amidopyrine and butadione].
    Doktorman RS; Groshovyĭ TA; Borzunov EE; Kozhakina IP; Koval' NA
    Farm Zh; 1977; (3):69-72. PubMed ID: 881027
    [No Abstract]   [Full Text] [Related]  

  • 17. 4(beta-benzoylvinyl)-antipyrine derivatives after antiphlogistic and analgesic activity.
    Massarani E; Nardi D; Magistretti MJ
    Arzneimittelforschung; 1969 Dec; 19(12):2020-2. PubMed ID: 5395897
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in the rat.
    Gaetani M; Debeus R; Vidi A; Coppi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:226-3. PubMed ID: 5067198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatal panmyelophthisis due to Rheopyrin].
    POGATSA G; SELLYEI M
    Orv Hetil; 1962 Mar; 103():504-5. PubMed ID: 14487379
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.
    Lambelin G; Roba J; Gillet C; Gautier M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):618-30. PubMed ID: 4987565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.